Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

(Z)-Ligustilide is a phthalide that has been found in A. graveolens and T. montana roots and has diverse biological activities.1,2,3,4 It inhibits autophagy and restores Nurr77 expression and sensitivity to tamoxifen (Item No. 13258) in tamoxifen-resistant MCF-7 cells.2 (Z)-Ligustilide (8-32 mg/kg) increases cerebral expression of Nrf2 and HO-1 and reduces infarct volume and neuronal loss in a rat model of cerebral ischemia and reperfusion injury.5 It decreases mechanical and thermal hyperalgesia in a rat model of inflammatory pain induced by complete Freund's adjuvant (CFA).3 (Z)-Ligustilide restores gait coordination, reduces spinal cord inducible nitric oxide synthase (iNOS) expression, and inhibits production of prostaglandin E2 (PGE2; Item No. 14010), TNF-α, and IL-1β in a rat model of spinal cord injury.4
WARNING This product is not for human or veterinary use.
1. Phthalides in roots of Anethum graveolens and Todaroa montana. Scientia Pharmaceutica 51(4), 414-417 (1983).
2. Sensitization of tamoxifen-
3. Ligustilide relieves complete Freund’s adjuvant-
4. Ligustilide treatment promotes functional recovery in a rat model of spinal cord injury via preventing ROS production. Int. J. Clin. Exp. Pathol. 8(10), 12005-12013 (2015).
5. Z-